Skip to main content
Clinical Trials/NCT03579342
NCT03579342
Completed
Not Applicable

Using App-technology and a Personalized Health Plan to Improve Lifestyle Habits Among Working Adults - a Randomized Controlled Trial

Karolinska Institutet1 site in 1 country209 target enrollmentApril 16, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lifestyle
Sponsor
Karolinska Institutet
Enrollment
209
Locations
1
Primary Endpoint
Health related quality of life assessed by the RAND-36 questionnaire
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The aim of this study is to evaluate if modern technology such as smartphone applications can be used to facilitate lifestyle changes and thereby improve health-related quality of life in gainfully employed persons in the general population in Stockholm, Sweden. The hypothesis is that at follow-up, the intervention group that use the new application will have improved health-related quality of life and other lifestyle habits including diet, physical activity and sleep, as well as biomarkers, compared to a control group.

Registry
clinicaltrials.gov
Start Date
April 16, 2018
End Date
May 15, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ylva Trolle Lagerros

MD, Associate professor

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Ability to communicate in Swedish
  • Have access to and use a smartphone

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Health related quality of life assessed by the RAND-36 questionnaire

Time Frame: 12-weeks follow-up

Mental and Physical Health Scores (range 0-100) are assessed using 36 questions

Secondary Outcomes

  • Physical activity(Baseline (week 0) and at 12-weeks follow-up)
  • HbA1c (Heamoglobin A1c)(Baseline (week 0) and at 12-weeks follow-up)
  • Total cholesterol(Baseline (week 0) and at 12-weeks follow-up)
  • Apolipoprotein A1(Baseline (week 0) and at 12-weeks follow-up)
  • Apolipoprotein B(Baseline (week 0) and at 12-weeks follow-up)
  • Body Mass Index(Baseline (week 0) and at 12-weeks follow-up)
  • Body weight(Baseline (week 0) and at 12-weeks follow-up)
  • Waist circumference(Baseline (week 0) and at 12-weeks follow-up)
  • Body composition(Baseline (week 0) and at 12-weeks follow-up)
  • Blood pressure (Systolic and Diastolic)(Baseline (week 0) and at 12-weeks follow-up)

Study Sites (1)

Loading locations...

Similar Trials